Granahan Investment Management »

Revance Therapeutics shares owned by Granahan Investment Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Granahan Investment Management from 13F filings

Historical chart of Granahan Investment Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Granahan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Granahan Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.1M 355k 11.47
2023-06-30 $7.3M 289k 25.31
2023-03-31 $7.8M 244k 32.21
2022-12-31 $6.4M 348k 18.46
2022-09-30 $6.6M 245k 27.00
2022-06-30 $3.1M 224k 13.82
2022-03-31 $3.2M 162k 19.50
2021-12-31 $3.5M 217k 16.32
2021-09-30 $3.6M 128k 27.86